Table 3.
Modulation of TNF/IL-10 ratio by PCT-233 and BUD pretreatment
| Time after LPS stimulation (days) | |||
|---|---|---|---|
| Pretreatment | 1 | 2 | 3 |
| Sham | 49·8 | 12·6 | 16·2 |
| PCT-233 (0·005%) | 3·0 | 1·1 | 1·6 |
| PCT-233 (0·05%) | 1·3 | 0·5 | 0·5 |
| BUD (1 nm) | 4·4 | 2·9 | 0·9 |
| BUD + PCT-233 (0·005%) | 0·9 | 0·2 | 0·2 |
| BUD + PCT-233 (0·05%) | 0·3 | 0·2 | 0·1 |
Alveolar macrophages were treated with PCT-233, BUD alone or in combination for 18 h before being stimulated with LPS (10 ng/ml) and cell-free supernatants were collected at different times after LPS stimulation. The ratio was calculated by dividing TNF levels by IL-10 levels (ng/ml).